Burzynski Research Institute Inc (BZYR)
0.043
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Burzynski Research Institute Enterprise Value: 5.651M for June 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 07, 2024 | 5.651M |
| June 06, 2024 | 5.651M |
| June 05, 2024 | 5.651M |
| June 04, 2024 | 5.651M |
| June 03, 2024 | 5.651M |
| May 31, 2024 | 5.651M |
| May 30, 2024 | 5.651M |
| May 29, 2024 | 5.651M |
| May 28, 2024 | 5.651M |
| May 24, 2024 | 5.651M |
| May 23, 2024 | 5.651M |
| May 22, 2024 | 5.150M |
| May 21, 2024 | 5.150M |
| May 20, 2024 | 5.150M |
| May 17, 2024 | 5.782M |
| May 16, 2024 | 5.782M |
| May 15, 2024 | 5.782M |
| May 14, 2024 | 5.782M |
| May 13, 2024 | 5.782M |
| May 10, 2024 | 5.782M |
| May 09, 2024 | 5.782M |
| May 08, 2024 | 5.782M |
| May 07, 2024 | 5.618M |
| May 06, 2024 | 5.618M |
| May 03, 2024 | 5.618M |
| Date | Value |
|---|---|
| May 02, 2024 | 5.618M |
| May 01, 2024 | 5.618M |
| April 30, 2024 | 5.618M |
| April 29, 2024 | 5.618M |
| April 26, 2024 | 5.618M |
| April 25, 2024 | 5.618M |
| April 24, 2024 | 5.491M |
| April 23, 2024 | 5.491M |
| April 22, 2024 | 4.606M |
| April 19, 2024 | 3.416M |
| April 18, 2024 | 3.193M |
| April 17, 2024 | 3.193M |
| April 16, 2024 | 3.193M |
| April 15, 2024 | 3.193M |
| April 12, 2024 | 3.193M |
| April 11, 2024 | 3.193M |
| April 10, 2024 | 3.193M |
| April 09, 2024 | 3.193M |
| April 08, 2024 | 3.193M |
| April 05, 2024 | 3.193M |
| April 04, 2024 | 3.193M |
| April 03, 2024 | 5.638M |
| April 02, 2024 | 5.638M |
| April 01, 2024 | 5.504M |
| March 28, 2024 | 4.665M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.012M
Minimum
Jun 12 2020
13.14M
Maximum
Jan 30 2023
4.202M
Average
3.825M
Median
May 20 2021
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.598M |
| Palatin Technologies Inc | 20.16M |
| iBio Inc | 29.25M |
| Theriva Biologics Inc | -10.75M |
| Oragenics Inc | 7.130M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.3629M |
| Total Expenses (Quarterly) | 0.3629M |
| Earnings Yield | -17.20% |